Toxicogenomics and new drug discovery

被引：0
|
作者：
Ulrich, RG [1 ]
机构：
[1] Merck Res Labs, Rosetta Inpharmat, Kirkland, WA 98034 USA
来源：
DRUG METABOLISM REVIEWS | 2002年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
3
引用
收藏
页码：2 / 2
页数：1
相关论文
共 50 条
  • [1] Use of toxicogenomics in drug discovery
    Blomme, E. A. G.
    Yang, Y.
    Waring, J. F.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2006, 161 (03) : 201 - 201
  • [2] Toxicogenomics, drug discovery, and the pathologist
    Boorman, GA
    Anderson, SP
    Casey, WM
    Brown, RH
    Crosby, LM
    Gottschalk, K
    Easton, M
    Ni, H
    Morgan, KT
    TOXICOLOGIC PATHOLOGY, 2002, 30 (01) : 15 - 27
  • [3] Strategic applications of toxicogenomics in early drug discovery
    Ryan, Timothy P.
    Stevens, James L.
    Thomas, Craig E.
    CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (05) : 654 - 660
  • [4] Strategic Application of Toxicogenomics in Early Drug Discovery
    Stevens, James
    DRUG METABOLISM REVIEWS, 2010, 42 : 3 - 4
  • [5] Toxicogenomics in Drug Discovery and Development - Making an Impact
    Wills, Quin
    Mitchell, Cathrine
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2009, 37 : 33 - 37
  • [6] Toxicogenomics and drug discovery: will new technologies help us produce better drugs?
    Roger Ulrich
    Stephen H. Friend
    Nature Reviews Drug Discovery, 2002, 1 : 84 - 88
  • [7] Toxicogenomics and drug discovery: will new technologies help us produce better drugs?
    Ulrich, R
    Friend, SH
    NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (01) : 84 - 88
  • [8] Current status and future prospects of toxicogenomics in drug discovery
    Khan, Saifur R.
    Baghdasarian, Argishti
    Fahlman, Richard P.
    Michail, Karim
    Siraki, Arno G.
    DRUG DISCOVERY TODAY, 2014, 19 (05) : 562 - 578
  • [9] Toxicogenomics in drug discovery and drug development: Potential applications and future challenges
    Khor, Tin Oo
    Ibrahim, Sherif
    Kong, Ah-Ng Tony
    PHARMACEUTICAL RESEARCH, 2006, 23 (08) : 1659 - 1664
  • [10] The importance of applying toxicogenomics to increase the efficiency of drug discovery
    Barros, SA
    PHARMACOGENOMICS, 2005, 6 (06) : 547 - 550
12345